Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer.

Ann Oncol · 2018 · PMC5961091 · PMID 29659677

Europe PMC DOI

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

borderline significanceP = 0.052so close (0.05 < p ≤ 0.1)

HER2 amplifications according to SISH were also correlated with KRAS wild-type status in 191 patients with mCRC and distant metastases, but only with borderline significance ( P = 0.052) [ 50 ].

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.